Expanded Access Treatment Protocol: Remdesivir for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) By midwayadmin|2020-05-19T15:28:26+00:00May 15th, 2020| Read More
Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants By midwayadmin|2020-05-15T15:34:56+00:00May 15th, 2020| Read More
D/C/F/TAF FDC Evaluated as a Fixed Dose Combination Regimen in Participants Switching from an Integrase Inhibitor who have Experienced Rapid Weight Gain By midwayadmin|2020-05-15T15:27:28+00:00May 15th, 2020| Read More
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With HIV-1 By midwayadmin|2020-05-15T15:18:14+00:00May 15th, 2020| Read More
A Phase 2/3 Study to Evaluate the Safety and Efficacy of GS-6207 in Combination with an Optimized Background Regimen in Heavily Treatment Experienced Subjects with HIV-1 Infection. By midwayadmin|2020-05-15T15:13:57+00:00May 15th, 2020| Read More
Study to Evaluate the Safety and Efficacy of Long-Acting Capsid Inhibitor GS-6207 in Combination With Other Antiretroviral Agents in People Living With HIV By midwayadmin|2020-05-15T15:08:12+00:00May 15th, 2020| Read More
Randomized, Double-blind, Efficacy, and Safety Study of Doravirine/Islatravir (DOR/ISL) in Treatment-naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection By midwayadmin|2020-05-15T15:04:15+00:00May 15th, 2020| Read More
Pharmacokinetic, Safety, and Efficacy of B/F/TAF in HIV-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimesters By midwayadmin|2019-07-10T16:32:13+00:00July 10th, 2019| Read More
A Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of Ridinalazole for 10 days with Vancomycin for 10 days in the treatment of Clostridium difficile (C Diff) Infection By midwayadmin|2019-04-24T18:12:28+00:00April 24th, 2019| Read More
A randomized, open label, multi-center, comparative trial, to assess the efficacy and safety of Pritelivir versus Foscarnet for the treatment of Acyclovir-resistant mucocutaneous HSV infections in immunocompromised adults By midwayadmin|2019-04-24T18:00:35+00:00April 24th, 2019| Read More
